New drug nearly doubles survival rates in some pancreatic cancer patients, study says
A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings are a significant marker of progress toward treating a notoriously deadly type of cancer, for which there have historically been limited effective options for therapies. The drug … Read more